While I do wish you luck, I'm also cautioning you about CVM's history. The company has tried the same drug against many different diseases. Over the years I've had stock in companies who's drugs have failed, they've gone on to develop new drugs, and try again. This is the only company I can remember that just keeps trying the same drug against different diseases.
As I understand it, they're now expressing the belief that it works against Covid-19 too. In the event of another failure you can bet that they'll try to sustain the company in the belief that it combats Covid.
There is a very simple function that most word processing programs can do, it's called search and replace. In the case of CVM, they have numerous statements that they've developed where essentially all they have to do is a search and replace and suddenly they've converted numerous releases that were originally written for curing AIDS to one that reads Covid-19 if that's the switch they wish to make. If you went back a decade or more and found releases from the company and compared them with those issued in the recent trial, I believe you'd find essentially the same manuscript, with only the disease targeted changed.
Gary
News 
Market Data 
Discover 
